SCHEMBL20967763

SCHEMBL20967763

CC(C)CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)ON3C(=O)CCC3=O)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ GSTP1 P09211 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ FTO Q9C0B1 9/20 0.35
▸ CYP2C19 P33261 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ SMAD3 P84022 1/20 0.34
▸ PRMT1 Q99873 1/20 0.34
▸ ACE2 Q9BYF1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29569825 0.91 ALDH1A1 (0.46) ALDH1A1CYP3A4HPGDTDP1HIF1A
SCHEMBL11993611 0.91 ALDH1A1 (0.46) ALDH1A1CYP3A4HPGDTDP1HIF1A
SCHEMBL29678518 0.88 ALDH1A1 (0.43) ALDH1A1CYP3A4HPGDTDP1HIF1A
SCHEMBL20340166 0.85 MEN1 (0.41) ALDH1A1CYP3A4HPGDTDP1HIF1A
SCHEMBL164316 0.80 FTO (0.56) ALDH1A1CYP3A4HPGDTDP1HSD17B10
SCHEMBL29501272 0.80 FTO (0.56) ALDH1A1CYP3A4HPGDTDP1HSD17B10
SCHEMBL29995636 0.80 FTO (0.56) ALDH1A1CYP3A4HPGDTDP1HSD17B10
SCHEMBL30064563 0.80 FTO (0.56) ALDH1A1CYP3A4HPGDTDP1HSD17B10
SCHEMBL19360153 0.78 CYP3A4 (0.40) ALDH1A1CYP3A4HPGDTDP1HSD17B10
SCHEMBL22434375 0.77 MAPT (0.63) ALDH1A1CYP3A4HPGDTDP1GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018174-A1 QUINONE METHIDE ANALOG SIGNAL AMPLIFICATION VENTANA MED SYST INC (US) 2024-01-18 — — US disclosed
US-11780863-B2 Quinone methide analog signal amplification VENTANA MEDICAL SYSTEMS, INC. (US) 2023-10-10 — — US disclosed
US-20190127405-A1 QUINONE METHIDE ANALOG SIGNAL AMPLIFICATION VENTANA MED SYST INC (US) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127405-A1 QUINONE METHIDE ANALOG SIGNAL AMPLIFICATION NQO2, SQOR, MRM1 ALDH1A1 208/4885CYP3A4 586/4885HPGD 634/4885
US-11780863-B2 Quinone methide analog signal amplification NQO2, SQOR, MRM1 ALDH1A1 208/4885CYP3A4 586/4885HPGD 634/4885
US-20240018174-A1 QUINONE METHIDE ANALOG SIGNAL AMPLIFICATION NQO2, SQOR, MRM1 ALDH1A1 208/4885CYP3A4 586/4885HPGD 634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback